Table of Contents
Chapter 1. Global Pharmaceutical Intermediates Market Executive Summary
1.1. Global Pharmaceutical Intermediates Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Intermediate Type
1.3.2. By Application
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Pharmaceutical Intermediates Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Pharmaceutical Intermediates Market Dynamics
3.1. Market Drivers
3.1.1. Growing Pharmaceutical Industry
3.1.2. Technological Advancements in Chemical Synthesis
3.1.3. Outsourcing and Contract Manufacturing
3.2. Market Challenges
3.2.1. Regulatory Compliance
3.2.2. High Cost of Production
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Growth in Personalized Medicine
Chapter 4. Global Pharmaceutical Intermediates Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Pharmaceutical Intermediates Market Size & Forecasts by Intermediate Type 2022-2032
5.1. Segment Dashboard
5.2. Global Pharmaceutical Intermediates Market: Intermediate Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Bulk Intermediate
5.2.2. Chemical Intermediate
Chapter 6. Global Pharmaceutical Intermediates Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Pharmaceutical Intermediates Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Anti-Infective Drugs
6.2.2. Analgesics
6.2.3. Antidiabetic Drugs
6.2.4. Cardiovascular Drugs
6.2.5. Antimicrobial Drugs
6.2.6. Anti-inflammatory Drugs
6.2.7. Others
Chapter 7. Global Pharmaceutical Intermediates Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Pharmaceutical Intermediates Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Biopharmaceutical Companies
7.2.2. CMO (Contract Manufacturing Organizations)
7.2.3. CRO (Contract Research Organizations)
7.2.4. Others
Chapter 8. Global Pharmaceutical Intermediates Market Size & Forecasts by Region 2022-2032
8.1. North America Pharmaceutical Intermediates Market
8.1.1. U.S. Pharmaceutical Intermediates Market
8.1.1.1. Intermediate Type breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Pharmaceutical Intermediates Market
8.2. Europe Pharmaceutical Intermediates Market
8.2.1. U.K. Pharmaceutical Intermediates Market
8.2.2. Germany Pharmaceutical Intermediates Market
8.2.3. France Pharmaceutical Intermediates Market
8.2.4. Spain Pharmaceutical Intermediates Market
8.2.5. Italy Pharmaceutical Intermediates Market
8.2.6. Rest of Europe Pharmaceutical Intermediates Market
8.3. Asia-Pacific Pharmaceutical Intermediates Market
8.3.1. China Pharmaceutical Intermediates Market
8.3.2. India Pharmaceutical Intermediates Market
8.3.3. Japan Pharmaceutical Intermediates Market
8.3.4. Australia Pharmaceutical Intermediates Market
8.3.5. South Korea Pharmaceutical Intermediates Market
8.3.6. Rest of Asia Pacific Pharmaceutical Intermediates Market
8.4. Latin America Pharmaceutical Intermediates Market
8.4.1. Brazil Pharmaceutical Intermediates Market
8.4.2. Mexico Pharmaceutical Intermediates Market
8.4.3. Rest of Latin America Pharmaceutical Intermediates Market
8.5. Middle East & Africa Pharmaceutical Intermediates Market
8.5.1. Saudi Arabia Pharmaceutical Intermediates Market
8.5.2. South Africa Pharmaceutical Intermediates Market
8.5.3. Rest of Middle East & Africa Pharmaceutical Intermediates Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Evonik
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Borregaard AS
9.3.3. Sudarshan Pharma
9.3.4. A.R. Life Science
9.3.5. Actylis
9.3.6. Saurav Chemicals Ltd.
9.3.7. Lianhetech
9.3.8. Midas Pharma GmbH
9.3.9. Sanofi
9.3.10. BASF SE
9.3.11. Chiracon GmbH
9.3.12. Lonza
9.3.13. Chemcon Speciality Chemicals Limited
9.3.14. Modepro India Pvt. Ltd.
9.3.15. Lifechem Pharma
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes